Rheumatoid arthritis

Juvenile idiopathic arthritis: recognition, diagnosis and conventional pharmacological management

Juvenile idiopathic arthritis is the most common chronic childhood rheumatic disease. Pharmacists are a vital part of the multidisciplinary team and should be aware of the considerations for pharmacological management.…

HRT associated with 46% increase in rheumatoid arthritis, suggest study results

Despite study results showing an increased risk of rheumatoid arthritis, the British Menopause Society cautions that the results are unlikely to change HRT prescribing practice.…

Rheumatoid arthritis: management

An overview of the medicines used for symptom control and disease modification, with consideration given to non-pharmacological approaches that support management of rheumatoid arthritis.…

Risk assessment for rheumatoid arthritis drug could result in fewer blood tests for patients, research suggests

Researchers have developed a risk-stratified monitoring system for toxicity linked to methotrexate to determine a patient's risk of abnormal blood test results.…

NSAIDs fail to reduce joint inflammation for people with arthritis of the knee, study results show

Comparing two groups of people with synovitis, researchers found that those treated with long-term oral non-steroidal anti-inflammatory drugs had worse synovitis than those not treated with the drugs.…

‘Milestone’ as NICE recommends biologics in moderate rheumatoid arthritis for the first time

Updated guidance from the National Institute for Health and Care Excellence will increase access to advanced therapies adalimumab, etanercept and infliximab within the NHS.…

Draft NICE guidance recommends first biologics for treatment of moderate rheumatoid arthritis

Final draft guidance from the National Institute for Health and Care Excellence states that adalimumab, etanercept and infliximab are recommended in the treatment of moderate rheumatoid arthritis.…

Trial suggests JAK1 inhibitor is superior to methotrexate for treatment of early rheumatoid arthritis

A selective Janus kinase inhibitor, upadacitinib, is superior to methotrexate in improving clinical outcomes in patients with rheumatoid arthritis, a study has suggested.…

A joint effort – the pivotal role of pharmacists in joint pain management

Pharmacists have an important role to play in the management of osteoarthritis and joint pain, but they also face significant barriers to becoming integrated within the multidisciplinary team.…

Supported content

Halting TNF-inhibitors in rheumatoid arthritis patients in remission could lead to significant savings, research reveals

Stopping tumour necrosis factor inhibitors in rheumatoid arthritis patients who are in remission or have low disease activity was associated with savings of more than €7,000.…